Related Experiment Video
Updated: Apr 17, 2026

Chronic Thromboembolic Pulmonary Hypertension and Assessment of Right Ventricular Function in the Piglet
Published on: November 4, 2015
Chronic thromboembolic pulmonary hypertension.
Chronic thromboembolic pulmonary hypertension (CTEPH) is a serious condition often stemming from unresolved pulmonary embolism. Pulmonary endarterectomy (PEA) offers a cure, but careful patient selection is crucial for successful surgical outcomes.
Area of Science:
- Cardiology
- Pulmonary Medicine
- Vascular Surgery
Background:
- Chronic thromboembolic pulmonary hypertension (CTEPH) is a severe, progressive disease linked to unresolved pulmonary embolism.
- The incidence of CTEPH, historically underestimated, may affect up to 3.8% of patients post-acute pulmonary embolism.
- While medical management offers supportive care, pulmonary endarterectomy (PEA) remains the only curative treatment for CTEPH.
Approach:
- This review synthesizes current knowledge on CTEPH pathophysiology.
- It examines clinical presentation and diagnostic challenges.
- The review covers surgical treatment (PEA), post-operative outcomes, and medical options for inoperable cases.
Key Points:
- Pulmonary endarterectomy (PEA) is the definitive treatment for CTEPH.
- Accurate patient screening is essential to identify candidates who will benefit from PEA.
- Understanding diagnostic pitfalls is critical for timely CTEPH diagnosis.
- Medical therapies are being explored for patients unsuitable for surgery.
Conclusions:
- CTEPH requires specialized management, with PEA as the primary curative option.
- Effective management hinges on early diagnosis and appropriate patient selection for surgery.
- Further research into medical treatments for inoperable CTEPH is warranted.
More Related Videos
07:41Induction and Phenotyping of Acute Right Heart Failure in a Large Animal Model of Chronic Thromboembolic Pulmonary Hypertension
Published on: March 17, 2022
06:59Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
Published on: August 26, 2025
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Pulmonary Embolism I: Introduction
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Chronic Obstructive Pulmonary Disease-I: Introduction